MYOMA
MCID: MYM001
MIFTS: 57

Myoma (MYOMA)

Categories: Cancer diseases, Muscle diseases, Reproductive diseases

Aliases & Classifications for Myoma

MalaCards integrated aliases for Myoma:

Name: Myoma 12 56 45 15 74
Neoplasms, Muscle Tissue 45 74
Muscle Benign Neoplasm 12 15
Myomatous Neoplasm 12 74
Benign Neoplasm of the Muscle 12
Muscle Tissue Neoplasm 12
Neoplasm of Muscle 12
Muscle Neoplasms 56
Muscle Neoplasm 12
Myomatous Tumor 12

Classifications:



External Ids:

Disease Ontology 12 DOID:2691 DOID:461
NCIt 51 C4063 C4882
SNOMED-CT 69 66357004 92237006
ICD10 34 D21

Summaries for Myoma

Disease Ontology : 12 A muscle benign neoplasm that is characterized as benign hyperplastic lesions of uterine smooth muscle cells.

MalaCards based summary : Myoma, also known as neoplasms, muscle tissue, is related to leiomyomatosis and intravenous leiomyomatosis, and has symptoms including muscle weakness, myoclonus and myalgia. An important gene associated with Myoma is PGR (Progesterone Receptor), and among its related pathways/superpathways is Aromatase Inhibitor Pathway (Breast Cell), Pharmacodynamics. The drugs Leuprolide and Dimenhydrinate have been mentioned in the context of this disorder. Affiliated tissues include uterus, bone and smooth muscle, and related phenotypes are cellular and homeostasis/metabolism

Wikipedia : 77 Myoma is a kind of mesenchymal... more...

Related Diseases for Myoma

Diseases related to Myoma via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 170)
# Related Disease Score Top Affiliating Genes
1 leiomyomatosis 30.5 ESR1 GNRH1 MED12 PGR
2 intravenous leiomyomatosis 30.5 DES ESR1
3 leiomyosarcoma 30.4 DES MED12 PGR
4 pleomorphic lipoma 30.4 HMGA2 PGR
5 leiomyoma, uterine 30.3 ESR1 HMGA2 PGR
6 adenomyosis 30.2 CYP19A1 ESR1 GNRH1 HOXA10 PGR
7 diffuse peritoneal leiomyomatosis 30.1 ESR1 MED12 PGR
8 uterine sarcoma 30.1 CYP19A1 DES ESR1
9 adhesions of uterus 30.0 ESR1 HOXA10
10 polycystic ovary syndrome 30.0 CYP19A1 GNRH1 LEP
11 benign metastasizing leiomyoma 29.9 CYP19A1 DES PGR
12 endometrial stromal sarcoma 29.9 CYP19A1 DES ESR1 PGR
13 endometriosis 29.8 CYP19A1 ESR1 GNRH1 HOXA10 PGR
14 endometrial cancer 29.6 CYP19A1 ESR1 GNRH1 HOXA10 PGR
15 endometrial adenocarcinoma 29.6 ESR1 HOXA10 PGR
16 leiomyoma 29.4 CYP19A1 DES ESR1 GNRH1 HMGA2 MED12
17 skeletal muscle neoplasm 12.1
18 dartoic leiomyoma 11.3
19 carney complex variant 11.1
20 skeletal muscle cancer 11.0
21 muscle cancer 11.0
22 mixed endometrial stromal and smooth muscle tumor 11.0
23 uterus leiomyosarcoma 10.8
24 vestibular gland benign neoplasm 10.4 ESR1 PGR
25 bartholin's gland adenoma 10.4 ESR1 PGR
26 vulvar syringoma 10.4 ESR1 PGR
27 lung leiomyoma 10.4 ESR1 PGR
28 glassy cell carcinoma of the cervix 10.4 ESR1 PGR
29 vulvar benign neoplasm 10.4 ESR1 PGR
30 trigonitis 10.4 ESR1 PGR
31 vulvar leiomyoma 10.4 ESR1 PGR
32 predominantly cortical thymoma 10.4 ESR1 PGR
33 breast medullary carcinoma 10.4 ESR1 PGR
34 breast scirrhous carcinoma 10.4 ESR1 PGR
35 bartholin's gland benign neoplasm 10.4 ESR1 PGR
36 oncocytic breast carcinoma 10.4 ESR1 PGR
37 bizarre leiomyoma 10.4 MED12 PGR
38 progesterone resistance 10.4 ESR1 PGR
39 thrombosis 10.4
40 endometrial squamous cell carcinoma 10.4 ESR1 PGR
41 cribriform carcinoma 10.4 ESR1 PGR
42 endometrial mucinous adenocarcinoma 10.4 ESR1 PGR
43 adenoid basal cell carcinoma 10.4 ESR1 PGR
44 apocrine adenocarcinoma 10.4 ESR1 PGR
45 deep angioma 10.4 ESR1 PGR
46 hypertensive encephalopathy 10.4 CYP19A1 EPO
47 synchronous bilateral breast carcinoma 10.4 ESR1 PGR
48 breast adenoid cystic carcinoma 10.4 ESR1 PGR
49 female reproductive endometrioid cancer 10.3 ESR1 PGR
50 cervical carcinosarcoma 10.3 ESR1 PGR

Graphical network of the top 20 diseases related to Myoma:



Diseases related to Myoma

Symptoms & Phenotypes for Myoma

UMLS symptoms related to Myoma:


muscle weakness, myoclonus, myalgia, torticollis, muscle cramp, muscle rigidity, muscle spasticity

MGI Mouse Phenotypes related to Myoma:

47 (show all 14)
# Description MGI Source Accession Score Top Affiliating Genes
1 cellular MP:0005384 10.18 CD3E CYP19A1 DES EPO ESR1 LEP
2 homeostasis/metabolism MP:0005376 10.18 CYP19A1 DES EPO ESR1 GNRH1 HPSE2
3 endocrine/exocrine gland MP:0005379 10.15 CD3E CYP19A1 ESR1 GNRH1 HOXA10 LEP
4 cardiovascular system MP:0005385 10.14 CYP19A1 DES EPO ESR1 LEP MED12
5 integument MP:0010771 10.11 CD3E CYP19A1 EPO ESR1 GNRH1 LEP
6 mortality/aging MP:0010768 10.1 CD3E DES EPO ESR1 HPSE2 LEP
7 digestive/alimentary MP:0005381 10.05 CYP19A1 ESR1 GNRH1 HOXA10 HPSE2 LEP
8 limbs/digits/tail MP:0005371 9.91 EPO ESR1 HOXA10 LEP MED12 PGR
9 nervous system MP:0003631 9.91 CD3E CYP19A1 ESR1 GNRH1 HOXA10 LEP
10 muscle MP:0005369 9.85 CYP19A1 DES EPO ESR1 LEP PGR
11 neoplasm MP:0002006 9.8 CD3E ESR1 GNRH1 LEP PGR XRCC4
12 renal/urinary system MP:0005367 9.63 CYP19A1 ESR1 GNRH1 HPSE2 LEP OXT
13 reproductive system MP:0005389 9.56 CYP19A1 ESR1 GNRH1 HOXA10 LEP OXT
14 skeleton MP:0005390 9.28 CYP19A1 EPO ESR1 GNRH1 HOXA10 LEP

Drugs & Therapeutics for Myoma

Drugs for Myoma (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 449)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Leuprolide Approved, Investigational Phase 4,Phase 3,Phase 1,Phase 2 53714-56-0 657181 3911
2
Dimenhydrinate Approved Phase 4 523-87-5 441281
3
Hyaluronic acid Approved, Vet_approved Phase 4,Phase 1,Phase 2 9004-61-9 53477741
4
Dienogest Approved Phase 4 65928-58-7
5
Nandrolone decanoate Approved, Illicit Phase 4 360-70-3 9677
6
Nandrolone phenpropionate Approved, Illicit, Investigational Phase 4 62-90-8 229455
7
Desogestrel Approved Phase 4 54024-22-5 40973
8
Goserelin Approved Phase 4,Phase 3 65807-02-5 5311128 47725
9
Cyclophosphamide Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 6055-19-2, 50-18-0 2907
10
Doxorubicin Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 23214-92-8 31703
11
Morphine Approved, Investigational Phase 4,Phase 3,Phase 1,Phase 2 57-27-2 5288826
12
Zinc oxide Approved Phase 4 1314-13-2
13
Calcium Carbonate Approved, Investigational Phase 4,Phase 3 471-34-1
14
Everolimus Approved Phase 4,Phase 3,Phase 2,Phase 1 159351-69-6 6442177 70789204
15
Sirolimus Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 53123-88-9 46835353 6436030 5284616
16
Miconazole Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1 22916-47-8 4189
17
Anastrozole Approved, Investigational Phase 4,Phase 3 120511-73-1 2187
18
Letrozole Approved, Investigational Phase 4,Phase 2,Phase 1 112809-51-5 3902
19
Lidocaine Approved, Vet_approved Phase 4,Phase 2,Not Applicable 137-58-6 3676
20
Misoprostol Approved Phase 4,Phase 3,Phase 2 59122-46-2 5282381
21
Dinoprostone Approved Phase 4,Not Applicable 363-24-6 5280360
22
Oxycodone Approved, Illicit, Investigational Phase 4 76-42-6 5284603
23
leucovorin Approved Phase 4,Phase 2 58-05-9 6006 143
24
Tocopherol Approved, Investigational Phase 4 1406-66-2 14986
25
Ferrous fumarate Approved Phase 4 141-01-5
26
Methylcobalamin Approved, Experimental, Investigational Phase 4 13422-55-4
27
Zinc Approved, Investigational Phase 4 7440-66-6 32051
28
Hydroxocobalamin Approved Phase 4 13422-51-0 11953898 15589840
29
Nicotinamide Approved, Investigational Phase 4,Phase 2 98-92-0 936
30
Cetrorelix Approved, Investigational Phase 4 120287-85-6 25074887 16129715
31
Acetaminophen Approved Phase 4,Phase 1 103-90-2 1983
32
Ketorolac Approved Phase 4 66635-83-4, 74103-06-3 3826
33
Ibuprofen Approved Phase 4,Not Applicable 15687-27-1 3672
34
Ethanol Approved Phase 4,Not Applicable 64-17-5 702
35
Mifepristone Approved, Investigational Phase 4,Phase 2,Phase 3,Phase 1 84371-65-3 55245
36
Levonorgestrel Approved, Investigational Phase 4,Not Applicable 17489-40-6, 797-63-7 13109
37
Progesterone Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1 57-83-0 5994
38
Dexamethasone Approved, Investigational, Vet_approved Phase 4,Phase 2,Not Applicable 50-02-2 5743
39
Dexamethasone acetate Approved, Investigational, Vet_approved Phase 4,Phase 2,Not Applicable 1177-87-3
40
Nitrous oxide Approved, Vet_approved Phase 4,Not Applicable 10024-97-2 948
41
Tranexamic Acid Approved Phase 4,Phase 2,Phase 3,Not Applicable 1197-18-8 5526
42
Pregabalin Approved, Illicit, Investigational Phase 4 148553-50-8 5486971
43
Celecoxib Approved, Investigational Phase 4 169590-42-5 2662
44
Glycine Approved, Nutraceutical, Vet_approved Phase 4,Phase 1,Not Applicable 56-40-6 750
45
Folic Acid Approved, Nutraceutical, Vet_approved Phase 4,Phase 2 59-30-3 6037
46
Beta carotene Approved, Nutraceutical Phase 4 7235-40-7
47
Calcium Approved, Nutraceutical Phase 4,Phase 3,Phase 1,Not Applicable 7440-70-2 271
48
Vitamin C Approved, Nutraceutical Phase 4,Phase 3 50-81-7 5785 54670067
49
Vitamin E Approved, Nutraceutical, Vet_approved Phase 4 59-02-9 14985
50
Vitamin D3 Approved, Nutraceutical Phase 4,Not Applicable 67-97-0 5280795 6221

Interventional clinical trials:

(show top 50) (show all 595)
# Name Status NCT ID Phase Drugs
1 Ulipristal Acetate for the Preoperative Management of Hypoechoic Cellular Leiomyomas Unknown status NCT02361905 Phase 4 ulipristal acetate;Leuprolide acetate
2 Ulipristal Acetate Versus GnRH Analogue Treatment Before Hysteroscopic Resection of Uterine Leiomyoma Unknown status NCT02361879 Phase 4 ulipristal acetate;Leuprolide acetate
3 Ulipristal Acetate Versus GnRH Analogue and Myometrial Preservation Unknown status NCT02357563 Phase 4 ulipristal acetate;Leuprolide acetate
4 Seprafilm Slurry in the Prevention of Uterine Scarring in Patients Undergoing Hysteroscopic Myomectomy Unknown status NCT01632202 Phase 4
5 IVF Outcome Following Treatment With Ulipristal Acetate for Myomatous Uterus After at Least One IVF Failure Unknown status NCT02601196 Phase 4 Ulipristal acetate
6 Endometrial Preparation Before Operative Hysteroscopy in Premenopausal Women Unknown status NCT02440750 Phase 4 Dienogest;Ulipristal acetate
7 Study of the Efficacy of Dienogest in the Treatment of Uterine Leiomyomas When Compared to Desogestrel and Goserelin Unknown status NCT01738724 Phase 4 Dienogest;Goserelin;Desogestrel
8 High Intensity Focused Ultrasound Ablation Virus Myomectomy to Treat Uterine Fibroids Unknown status NCT01239641 Phase 4
9 EpSSG (European Soft Tissue Sarcoma Study Group) Protocol for Non-Metastatic Rhabdomyosarcoma in Children Unknown status NCT00339118 Phase 4 doxorubicin, cytoxan
10 Pilot of Letrozole for Uterine Myomas Completed NCT02470741 Phase 4 Letrozole
11 Randomized Controlled Trial (RCT)Comparing GYNAECARE MORCELLEX Versus ROTOCUT GI Tissue Morcellators Completed NCT00743080 Phase 4
12 Intravenous or Intra-abdominal Local Anesthetics for Postoperative Pain Management. Completed NCT01492179 Phase 4 Normal saline;Intravenous Lidocaine;Intra-abdominal Lidocaine
13 Single Versus Double Dose Intra-vaginal Prostaglandin E2 "Misoprostol" Prior Abdominal Myomectomy Completed NCT02154932 Phase 4 2 doses 400 microgram misoprostol;single dose misoprostol
14 Vasopressin Administration During Laparoscopic Myomectomy: a Randomized Controlled Trial Completed NCT01393704 Phase 4 Vasopressin
15 Morphine vs. Oxycodone for Postoperative Pain Management Completed NCT00528177 Phase 4 Morphine and oxycodone
16 The FIRSTT: Comparing MRgFUS(MR-guided Focused Ultrasound) Versus UAE (Uterine Artery Embolization)for Uterine Fibroids. Completed NCT00995878 Phase 4
17 SIGnificance of Routine Hysteroscopy Prior to a First 'in Vitro Fertilization'(IVF) Treatment Cycle Completed NCT01242852 Phase 4
18 Fibroids in Women of Reproductive Age and Women Pregnancy Completed NCT02620345 Phase 4 Dydrogesterone M ( case 1 );Dydrogesterone M ( case 2 )
19 Intra-arterial Lidocaine for Pain Control Post Uterine Fibroid Embolization Completed NCT02293447 Phase 4 Lidocaine per-embolization;Lidocaine post-embolization
20 Novel MRI Strategies as a Non-invasive Biomarker in Women With Uterine Fibroids Completed NCT00746031 Phase 4 GnRH analogue (Zoladex);GnRH antagonist-Cetrorelix
21 Safety Trial of Magnetic Resonance (MR) Guided Focused Ultrasound Surgery (FUS) in Women With Uterine Fibroids Wishing to Pursue Pregnancy in the Future Completed NCT00180739 Phase 4
22 Efficacy Study of Magnetic Resonance (MR) Guided Focused Ultrasound in the Treatment of Large Fibroids Completed NCT00159328 Phase 4
23 Effectiveness of IV Acetaminophen and IV Ibuprofen in Reducing Post Procedural Pain in the UFE Procedure Completed NCT02227316 Phase 4 IV Ibuprofen;IV Acetaminophen;Intravenous placebo/Intravenous placebo
24 A Prospective Study Comparing Contour SE™ Microspheres to Embosphere® Microspheres for Treating Symptomatic Uterine Fibroids With Uterine Fibroid Embolization (UFE) Completed NCT00628901 Phase 4
25 Efficacity Assessment of PREVADH® in Adhesion Prevention in Gynaecologic Surgery Completed NCT01388907 Phase 4
26 Efficacy and Safety of Rapamycin (Sirolimus) in the Treatment of Symptomatic Uterine Fibroids and Leiomyomatosis Recruiting NCT03500367 Phase 4 rapamycin
27 Combined Vaginal Misoprostol and Perivascular Vasopressin Recruiting NCT03815344 Phase 4 Standard;Standard-vaginal misoprostol
28 A Study on the Mifepristone Tablets in the Treatment of Symptomatic Uterine Fibroids With Safety and Efficacy Recruiting NCT03210324 Phase 4 Mifepristone tablets
29 Aromatase Plus GnRH Analogue Versus Ulippristal Acetate in Uterine Fibroids Recruiting NCT03421639 Phase 4 Ulipristal acetate;Aromatase inhibitor plus GnRH analog
30 Treatment of Heavy Menstrual Bleeding in Women With Uterine Fibroids Recruiting NCT03317795 Phase 4 Levonorgestrel IUS;Tranexamic Acid
31 Misoprostol for Reduction of Blood Loss During Fibroid Surgery Recruiting NCT02209545 Phase 4 Misoprostol;Placebo
32 Ulipristal Use in Chinese Population Active, not recruiting NCT02825719 Phase 4 Ulipristal acetate;Ferrous sulphate;Tranexamic Acid
33 Peritoneal Cavity Conditioning Decreases Pain, Inflammation and Adhesions Terminated NCT01344486 Phase 4
34 Preemptive Analgesia Following Uterine Artery Embolization Terminated NCT01555073 Phase 4 pregabalin/celecoxib;pregabalin/placebo;celecoxib/placebo;Placebo group
35 Single Incision Laparoscopic Surgery (SILS) Versus Conventional Laparoscopic Hysterectomy Unknown status NCT01483417 Phase 3
36 Long Term Prevention of Nausea and Vomiting in Gynecologic Laparoscopy Unknown status NCT02011659 Phase 3 Ramosetron
37 Single-port Access Laparoscopic-assisted Vaginal Hysterectomy Unknown status NCT01048931 Phase 3
38 The Use of Doppler to Diagnose Myometrial Masses Unknown status NCT01833871 Phase 2, Phase 3
39 Combination Chemotherapy in Treating Young Patients With Nonmetastatic Rhabdomyosarcoma Unknown status NCT00379457 Phase 3 carboplatin;cyclophosphamide;doxorubicin hydrochloride;etoposide;ifosfamide;topotecan hydrochloride;vincristine sulfate;vinorelbine tartrate
40 Study of Tumor-shrinking Decoction (TSD) to Treat Symptomatic Uterine Fibroids Unknown status NCT02189083 Phase 3 TSD
41 Influence of Aromatase Inhibitors and GnRH Analogs to Treat Uterine Leiomyoma by Vaginal Hysterectomy Unknown status NCT01280045 Phase 3
42 Clinical Trial of Uterine Artery Embolization for Uterine Leiomyoma Unknown status NCT00821275 Phase 2, Phase 3
43 Vincristine, Dactinomycin, and Cyclophosphamide With or Without Radiation Therapy in Treating Patients With Newly Diagnosed Low-Risk Rhabdomyosarcoma Unknown status NCT00075582 Phase 3 dactinomycin;cyclophosphamide;vincristine sulfate
44 PGL4001 Versus GnRH-agonist in Uterine Myomas Completed NCT00740831 Phase 3 PGL4001;leuprorelin
45 PGL4001 Versus Placebo in Uterine Myomas Completed NCT00755755 Phase 3 PGL4001 (ulipristal) and iron;PGL4001 matching placebo and iron;PGL4001 (ulipristal) and iron
46 Barbed Suture in Single-port Laparoscopic Myomectomy Completed NCT01984632 Phase 3
47 Vasopressin Versus Epinephrine in Myomectomy Completed NCT01861015 Phase 3 Epinephrine;Vasopressin
48 Study on the Effect of Intravenous Ascorbic Acid on Intraoperative Blood Loss in Women With Uterine Myoma Completed NCT01715597 Phase 3 ascorbic acid;Normal saline
49 PGL4001 Efficacy Assessment in Reduction of Symptoms Due to Uterine Leiomyomata Completed NCT01642472 Phase 3 Ulipristal Acetate - open label
50 PGL4001 Efficacy Assessment in Reduction of Symptoms Due to Uterine Leiomyomata Completed NCT01156857 Phase 3 PGL4001, placebo;PGL4001, progestin

Search NIH Clinical Center for Myoma

Cochrane evidence based reviews: myoma

Genetic Tests for Myoma

Anatomical Context for Myoma

MalaCards organs/tissues related to Myoma:

42
Uterus, Bone, Smooth Muscle, T Cells, Breast, Lung, Testes

Publications for Myoma

Articles related to Myoma:

(show top 50) (show all 630)
# Title Authors Year
1
Identification of the molecular relationship between intravenous leiomyomatosis and uterine myoma using RNA sequencing. ( 30723247 )
2019
2
Disappearance of a myoma after pregnancy in a 38 years old patient, treated by Ulipristal Acetate without success before getting pregnant. ( 30898625 )
2019
3
More Than a Myoma: A Review of Myomatous Erythrocytosis Syndrome. ( 30904341 )
2019
4
The uterine fibroid/myoma tumour: analysis of the global research architecture using density-equalizing mapping. ( 29198424 )
2018
5
Acute intestinal obstruction due to extrinsic compression by previa myoma and ectopic pregnancy: a case report. ( 29335010 )
2018
6
Transvaginal Natural Orifice Transluminal Endoscopic Surgery Myomectomy: A Novel Route for Uterine Myoma Removal. ( 29410143 )
2018
7
Recurrence of uterine myoma after myomectomy: Open myomectomy versus laparoscopic myomectomy. ( 29227004 )
2018
8
Modern Myoma Treatment in the Last 20 Years: A Review of the Literature. ( 29789793 )
2018
9
Expression and prognostic value of lactate dehydrogenase-A and -D subunits in human uterine myoma and uterine sarcoma. ( 29620641 )
2018
10
The expression of MA1llerian inhibiting substance/anti-MA1llerian hormone type II receptor in myoma and adenomyosis. ( 29372159 )
2018
11
Dehiscence of a Low Transverse Cesarean Scar by a Submucous Myoma in a Nongravid Uterus. ( 29709694 )
2018
12
Matrix metalloproteinase activity correlates with uterine myoma volume reduction after ulipristal acetate treatment. ( 29408988 )
2018
13
Diagnosis and treatment of submucous myoma of the uterus with interventional ultrasound. ( 29616100 )
2018
14
Multimodal imaging for diagnosis and management of parasitic peritoneal myoma with myxoid degeneration after laparoscopic-assisted myomectomy with electric power morcellation. ( 29516586 )
2018
15
Morbidity, fertility and pregnancy outcomes after myoma enucleation by laparoscopy versus laparotomy. ( 29417281 )
2018
16
Multidisciplinary Approach in Large Sized Submucosal Myoma: Hysteroscopic Myomectomy after Uterine Artery Embolization. ( 29969685 )
2018
17
Incarceration of early gravid uterus with adenomyosis and myoma: report of two patients managed with uterine reduction. ( 30254999 )
2018
18
Regarding "Multidisciplinary Approach in Large-Sized Submucous Myoma: Hysteroscopic Myomectomy after Uterine Artery Embolization". ( 30165186 )
2018
19
Health Education Using Telephone and WeChat in Treatment of Symptomatic Uterine Myoma with High-Intensity Focused Ultrasound. ( 30185767 )
2018
20
Blood Serum Levels of Proinflammatory Cytokines (IL-1β, IL-6, TNFα, IL-8, IL-12p70, and IFNγ) in Patients with Uterine Myoma. ( 30225705 )
2018
21
Size, Type, and Location of Myoma as Predictors for Successful Laparoscopic Myomectomy: A Tertiary Government Hospital Experience. ( 30254939 )
2018
22
Recurrent Cerebral Infarction Due to Benign Uterine Myoma. ( 30366865 )
2018
23
Perioperative outcomes of myomectomy for extreme myoma burden: A comparison of surgical approaches. ( 30391510 )
2018
24
Fibroid Imaging by Gynecological Surgeons Training in Intraoperative Ultrasound Technique. ( 30502500 )
2018
25
A case report of traditional Korean medicine treatments on uterine myoma with thyroid cancer. ( 30505680 )
2018
26
Regarding "Multidisciplinary Approach in Large-sized Submucosal Myoma: Hysteroscopic Myomectomy after Uterine Artery Embolization". ( 30580101 )
2018
27
Paradoxical embolism caused by ovarian vein thrombosis extending to inferior vena cava in a female with uterine myoma. ( 30595774 )
2018
28
Histiocyte-rich rhabdomyoblastic tumor: rhabdomyosarcoma, rhabdomyoma, or rhabdomyoblastic tumor of uncertain malignant potential? A histologically distinctive rhabdomyoblastic tumor in search of a place in the classification of skeletal muscle neoplasms. ( 30287926 )
2018
29
Dynamic thiol/disulphide homeostasis in patients with Uterine Myoma. ( 28697394 )
2017
30
Minimally Invasive Approaches to Myoma Management. ( 28734973 )
2017
31
Impact of pelvic magnetic resonance imaging findings in the indication of uterine artery embolization in the treatment of myoma. ( 28397200 )
2017
32
OUTCOME OF PREGNANCY WITH CLINICALLY VISIBLE/PALPABLE MYOMA AMONG WOMEN WHO UNDERGO CAESARIAN SECTION IN THREE TEACHING HOSPITALS, ADDIS ABABA, ETHIOPIA: A CROSS SECTIONAL STUDY. ( 29148636 )
2017
33
Psychiatric outcomes after hysterectomy in women with uterine myoma: a population-based retrospective cohort study. ( 28597115 )
2017
34
Pilot Study of the Mirabilis System Prototype for Rapid Noninvasive Uterine Myoma Treatment Using an Ultrasound-Guided Volumetric Shell Ablation Technique. ( 28109895 )
2017
35
Falsely Elevated Postvoid Residual Urine Volume in Uterine Myoma. ( 28503470 )
2017
36
Sacral Schwannoma Mimicking a Myoma Uterus. ( 28132872 )
2017
37
Pregnancy Outcomes After Direct Uterine Myoma Thermal Ablation: Review of the Literature. ( 28109894 )
2017
38
Unique Learning System for Uterine Artery Embolization for Symptomatic Myoma and Adenomyosis for Obstetrician-Gynecologists in Cooperation with Interventional Radiologists: Evaluation of UAE From the Point of View of Gynecologists Who Perform UAE. ( 28807810 )
2017
39
Myomectomies for massive hemoperitoneum from spontaneous bleeding of a uterine myoma. ( 28852453 )
2017
40
Increased risk of breast cancer in women with uterine myoma: a nationwide, population-based, case-control study. ( 28382798 )
2017
41
Urethrovaginal fistula following vaginal prolapse of a pedunculated uterine myoma: a case report. ( 29058627 )
2017
42
May-Thurner syndrome caused by a huge uterine myoma. ( 29296055 )
2017
43
Quality assessment of pelvic ultrasound for uterine myoma according to the CNGOF guidelines. ( 28643658 )
2017
44
Alcohol consumption and risk of uterine myoma: A systematic review and meta analysis. ( 29176884 )
2017
45
Novel management of a giant cervical myoma in a premenopausal patient. ( 28993358 )
2017
46
Incidence of Malignancy and Myoma Variants at Surgery for Presumed Benign Symptomatic Myomas. ( 28216458 )
2017
47
Myoma and myomectomy: Poor evidence concern in pregnancy. ( 28892210 )
2017
48
Rewriting the script: time to rethink the indications for myoma surgery. ( 28069179 )
2017
49
Myoma in Septic Necrobiosis at 10 Days Post-Partum. ( 29102219 )
2017
50
Laparoscopy or laparotomy as the way of entrance in myoma enucleation. ( 28819682 )
2017

Variations for Myoma

Expression for Myoma

Search GEO for disease gene expression data for Myoma.

Pathways for Myoma

Pathways related to Myoma according to GeneCards Suite gene sharing:

# Super pathways Score Top Affiliating Genes
1 9.23 CYP19A1 ESR1

GO Terms for Myoma

Biological processes related to Myoma according to GeneCards Suite gene sharing:

(show all 13)
# Name GO ID Score Top Affiliating Genes
1 regulation of signaling receptor activity GO:0010469 9.8 EPO GNRH1 LEP OXT
2 transcription initiation from RNA polymerase II promoter GO:0006367 9.69 ESR1 MED12 PGR
3 response to estradiol GO:0032355 9.54 ESR1 LEP OXT
4 stem cell differentiation GO:0048863 9.52 ESR1 HMGA2
5 female pregnancy GO:0007565 9.5 GNRH1 LEP OXT
6 response to electrical stimulus GO:0051602 9.48 EPO OXT
7 eating behavior GO:0042755 9.46 LEP OXT
8 androgen metabolic process GO:0008209 9.43 CYP19A1 ESR1
9 response to nutrient GO:0007584 9.43 CD3E EPO LEP
10 intracellular steroid hormone receptor signaling pathway GO:0030518 9.4 ESR1 MED12
11 ovulation from ovarian follicle GO:0001542 9.16 LEP PGR
12 response to prostaglandin E GO:0034695 8.96 GNRH1 OXT
13 uterus development GO:0060065 8.8 CYP19A1 ESR1 HOXA10

Molecular functions related to Myoma according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 RNA polymerase II proximal promoter sequence-specific DNA binding GO:0000978 9.46 ESR1 HMGA2 HOXA10 PGR
2 steroid binding GO:0005496 8.96 ESR1 PGR
3 hormone activity GO:0005179 8.92 EPO GNRH1 LEP OXT

Sources for Myoma

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
20 FMA
29 GO
30 GTR
31 HGMD
32 HMDB
33 HPO
34 ICD10
35 ICD10 via Orphanet
36 ICD9CM
37 IUPHAR
38 KEGG
39 LifeMap
41 LOVD
43 MedGen
45 MeSH
46 MESH via Orphanet
47 MGI
50 NCI
51 NCIt
52 NDF-RT
55 NINDS
56 Novoseek
58 OMIM
59 OMIM via Orphanet
63 PubMed
65 QIAGEN
70 SNOMED-CT via HPO
71 SNOMED-CT via Orphanet
72 TGDB
73 Tocris
74 UMLS
75 UMLS via Orphanet
Content
Loading form....